Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Plantar Fasciitis
NCT03054610Phase 1Completed
- Sponsor
- Universidad Autónoma de Nuevo León
- Start
- Jan 2015
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of botulinum toxin type A in plantar fasciitis, sponsored by Universidad Autónoma de Nuevo León. Primary endpoint: Foot and Ankle Disability Index at 6 months. Started Jan 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT03054610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054610.